Sanofi's dengue shot Dengvaxia wins FDA priority review despite controversial past

30th October 2018 Uncategorised 0

The FDA accepted Sanofi’s approval application for Dengvaxia, the dengue vaccine at the center of a safety scandal earlier this year in the Philippines. Now, the agency is set to decide on the vaccine for U.S. approval by May 1, 2019.

More: Sanofi's dengue shot Dengvaxia wins FDA priority review despite controversial past
Source: fierce